Treatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis

This publication has 33 references indexed in Scilit:

• Vascular Endothelial Growth Factor Can Substitute for Macrophage Colony-Stimulating Factor in the Support of Osteoclastic Bone Resorption
  The Journal of Experimental Medicine, 1999
• Regional Suppression of Tumor Growth byIn VivoTransfer of a cDNA Encoding a Secreted Form of the Extracellular Domain of theflt-1Vascular Endothelial Growth Factor Receptor
  Human Gene Therapy, 1998
• Angiogenesis: a critical process in the pathogenesis of RA--a role for VEGF?
  Rheumatology, 1996
• Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDR
  Biochemical and Biophysical Research Communications, 1996
• The Mouse Gene for Vascular Endothelial Growth Factor
  Journal of Biological Chemistry, 1996
• Suppression of Collagen-Induced Arthritis Using an Angiogenesis Inhibitor, AGM-1470, and a Microtubule Stabilizer, Taxol
  Cellular Immunology, 1994
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
  Proceedings of the National Academy of Sciences, 1993
• Angiogenesis inhibition suppresses collagen arthritis.
  The Journal of Experimental Medicine, 1992
• Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low‐dose methotrexate
  Arthritis & Rheumatism, 1989
• Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin
  Biochemistry, 1972